Cue Biopharma (CUE) SEC Filings & 10K Form $0.78 -0.02 (-2.63%) As of 04/16/2025 04:00 PM Eastern Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Recent Cue Biopharma SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView04/15/20253:44 PMCue Biopharma (Filer)Form 424B504/14/20254:17 PMCue Biopharma (Filer)Form 424B504/14/20253:00 PMCue Biopharma (Filer)Form PRE 14A03/31/20253:00 PMCue Biopharma (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 03/31/20253:00 PMCue Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/21/20256:14 PMBleichroeder LP (Filed by)Cue Biopharma (Subject)Form SCHEDULE 13G/A12/18/20243:00 PMCue Biopharma (Issuer)PASSERI DANIEL R (Reporting)Form 4Statement of changes in beneficial ownership of securities 11/29/20243:00 PMBaker Daniel G. (Reporting)Cue Biopharma (Issuer)Form 3Initial statement of beneficial ownership of securities 11/29/20243:00 PMBaker Daniel G. (Reporting)Cue Biopharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 10/07/20244:07 PMBleichroeder LP (Filed by)Cue Biopharma (Subject)Form SCHEDULE 13G/A10/04/20243:00 PMCue Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 09/27/20243:17 PMCue Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 09/27/20243:05 PMCue Biopharma (Filer)Form 424B509/26/20243:32 PMCue Biopharma (Filer)Form 424B509/10/20243:00 PMCue Biopharma (Filer)Form DEF 14A09/03/20243:30 PMCue Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/28/20243:00 PMCue Biopharma (Filer)Form PRE 14A08/16/20243:00 PMCue Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/25/20243:00 PMCue Biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/26/20242:43 PMCue Biopharma (Filer)Form ARS04/26/20242:46 PMCue Biopharma (Filer)Form DEFA14A(Data available from 1/1/2016 forward) Remove Ads Related Companies and Tools Related Companies DBVT SEC Filings NBTX SEC Filings DMAC SEC Filings CGC SEC Filings FULC SEC Filings DERM SEC Filings ACRS SEC Filings IPHA SEC Filings MOLN SEC Filings PBYI SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:CUE) was last updated on 4/17/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cue Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cue Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CUE Stock Free CUE Stock Alerts